Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jun 05, 2026
Why Is Guidewire Software (GWRE) Stock Down -11% Today?

Why Is Guidewire Software (GWRE) Stock Down -11% Today?

Key Takeaways

  • Shares of GWRE are declining approximately 11.10% on June 5, 2026, following Q3 fiscal 2026 earnings released after the previous session's close.
  • Despite beating both EPS and revenue estimates, the stock fell on disappointment over Annual Recurring Revenue (ARR) growth coming in at the low end of guidance and concerns over deal timing slippage.
  • Management acknowledged that several anticipated contracts did not close within the quarter, raising questions about whether the shortfall reflects temporary timing or a broader slowdown in insurance technology spending.
  • A leadership transition underway in Guidewire's sales department added further uncertainty to the near-term pipeline outlook.
  • The stock had been trading at elevated valuation multiples heading into the print, making it vulnerable to any miss — however slight — against high investor expectations.
  • Traders will be watching for analyst commentary, any rating changes, and whether the next quarter's guidance pipeline materializes as management expects.

Opening Summary

Guidewire Software (GWRE) is a San Mateo, California-based provider of cloud-based software solutions for the global property and casualty insurance industry, offering platforms for policy administration, billing, and claims management. Shares are declining 11.10% on June 5, 2026, dropping from the prior closing price of approximately $151.17 to around $133.94 in premarket trading. The selloff is an earnings-driven move, occurring despite the company reporting Q3 fiscal 2026 results that beat Wall Street estimates on both the top and bottom lines. Markets focused instead on ARR coming in at the lower bound of the guidance range and a pattern of deal timing delays that raised questions about forward revenue visibility.

Earnings Beat, But the Bar Was Higher

Guidewire reported Q3 fiscal 2026 non-GAAP EPS of $0.82, beating the consensus estimate of approximately $0.74 by roughly 10.4%, and revenue of $372.54 million — a 26.9% year-over-year increase — which surpassed analyst expectations of $355.99 million by approximately 4.7%. Gross margin expanded to 66%, and subscription and support gross margin improved to 74% from 71% a year earlier. The company also raised its full-year fiscal 2026 revenue guidance to a range of $1.46–$1.47 billion and increased its non-GAAP operating income outlook to $314–$324 million. On paper, these were strong results — but the market had priced in more.

ARR Disappointment and Deal Timing Concerns

The primary catalyst behind the post-earnings selloff in GWRE was Annual Recurring Revenue of $1.147 billion, which landed at the very low end of management's guided range of $1.144–$1.150 billion and represented 19% year-over-year growth. For a company whose cloud transition narrative rests heavily on ARR momentum, coming in at the floor of guidance — rather than the midpoint or ceiling — disappointed investors who expected continued acceleration. Management disclosed that several deals expected to close in Q3 were pushed into future quarters due to timing factors, not cancellations. While the company secured 11 new cloud contracts in the quarter, analysts questioned whether the timing delays signal a broader softening in insurance IT budget cycles or competitive pressure.

Sales Leadership Transition Adds Uncertainty

Compounding investor concern is an ongoing leadership transition in Guidewire's sales organization. Changes at the senior sales level during an active selling cycle introduce execution risk, particularly for a company that depends on a concentrated number of large enterprise deals each quarter. Any disruption in sales leadership continuity can affect deal progression, client relationships, and conversion timing — factors that are especially sensitive when ARR growth is already coming in at the low end of forecasts. While management expressed confidence in its pipeline, the combination of deal slippage and organizational change was enough to spook investors sitting on a stock that had already run significantly ahead of the broader software sector.

AI Spending Shifts and Competitive Landscape

Analysts also flagged evolving concerns around how insurance carriers are prioritizing technology spending in an environment where generative AI investments are increasingly competing for budget allocations. While Guidewire itself is incorporating AI-driven tools — including PricingCenter and ProNavigator — into its platform, there are questions about whether the pace of enterprise AI adoption in the insurance vertical could disrupt traditional software procurement timelines. Increased subcontractor costs in the services segment also weighed on margins modestly, signaling that scaling implementation capacity remains a cost challenge.

Market Context and Trading Activity

The sharp decline in GWRE is occurring against a backdrop of a broadly stable broader market, reinforcing that this is a company-specific, earnings-driven move rather than a macro selloff. The stock was trading at a premium valuation multiple relative to software peers heading into the print, which elevated the risk of a "sell the news" reaction even on a technical beat. The drop pushed the stock toward levels not seen since earlier in the year, breaking through key near-term technical support. The enterprise software ETF IGV did not exhibit comparable weakness in premarket, further isolating the move to Guidewire's specific results and guidance narrative.

Trending AI Robots

For traders navigating earnings-driven volatility in software stocks like GWRE, Tickeron's Trending AI Robots page highlights a curated selection of the platform's top-performing AI trading bots under live market conditions. Tickeron operates hundreds of AI-powered bots covering thousands of tickers across multiple strategies, timeframes, performance profiles, and asset types — but only the highest-performing bots under the current market environment are featured in the Trending section. Rankings update dynamically, ensuring the featured robots reflect what is working today rather than historical averages. Whether you are focused on momentum plays, mean-reversion setups, or sector-specific strategies, exploring the Trending AI Robots can help identify systematic approaches suited to today's conditions.

What Comes Next for GWRE

With Q3 now behind it, GWRE will face increased scrutiny on its Q4 fiscal 2026 pipeline execution, particularly around the deals that slipped from Q3. The company's next earnings report is expected to cover Q4 fiscal 2026, likely in September 2026, and will serve as a critical test of whether ARR growth re-accelerates or continues to moderate. Analysts will be closely watching how the new sales leadership beds in, whether the delayed Q3 deals convert in Q4 or beyond, and whether insurance carriers maintain their cloud migration spending priorities amid broader macro uncertainty. The consensus estimate for Q4 EPS currently stands around $1.00 on approximately $396.9 million in revenue. Risks include further deal timing slippage, competitive displacement by newer AI-native insurance platforms, and any macro-driven softening in enterprise IT budgets.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: GWRE

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


GWRE in +5.56% Uptrend, advancing for three consecutive days on August 24, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where GWRE advanced for three days, in of 312 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 24, 2026. You may want to consider a long position or call options on GWRE as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GWRE just turned positive on July 27, 2026. Looking at past instances where GWRE's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

GWRE moved above its 50-day moving average on July 24, 2026 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 200 cases where GWRE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 13 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GWRE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GWRE broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GWRE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GWRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.136) is normal, around the industry mean (28.672). P/E Ratio (103.167) is within average values for comparable stocks, (79.190). Projected Growth (PEG Ratio) (1.053) is also within normal values, averaging (1.753). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (11.628) is also within normal values, averaging (70.832).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.58B. The market cap for tickers in the group ranges from 291 to 253.67B. SAP holds the highest valuation in this group at 253.67B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 0%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was 11%. PSQH experienced the highest price growth at 44%, while CXAI experienced the biggest fall at -98%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was -13% and the average quarterly volume growth was 85%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 76
Price Growth Rating: 54
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
GWRE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of software products for property and casualty insurers

Industry PackagedSoftware

Profile
Details
Industry
Information Technology Services
Address
970 Park Pl.
Phone
+1 650 357-9100
Employees
3415
Web
https://www.guidewire.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.